CAS: 1089736-73-1 - N-(1-Oxopentyl-2,2,3,3,4,4,5,5,5-d<sub>9</sub>)-N-[[2′-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-<span class="text-smallcaps">L</span>-valine
Fórmula:C24H20D9N5O3
InChI:InChI=1S/C24H29N5O3/c1-4-5-10-21(30)29(22(16(2)3)24(31)32)15-17-11-13-18(14-12-17)19-8-6-7-9-20(19)23-25-27-28-26-23/h6-9,11-14,16,22H,4-5,10,15H2,1-3H3,(H,31,32)(H,25,26,27,28)/t22-/m0/s1/i1D3,4D2,5D2,10D2
Chave InChI:InChIKey=ACWBQPMHZXGDFX-KDDXQTGLSA-N
SMILES:O=C(O)C(N(C(=O)CCCC)CC=1C=CC(=CC1)C=2C=CC=CC2C3=NN=NN3)C(C)C
Marca | Dados do produto | Pureza | Gama de preços | Estimativa de entrega |
---|---|---|---|---|
rac-Valsartan-d9 REF: 4Z-V-022CAS: 1089736-73-1 | - - - | A consultar | Ter 03 Dez 24 | |
Valsartan-d9 REF: 4Z-V-0248CAS: 1089736-73-1 | - - - | A consultar | Ter 03 Dez 24 | |
Valsartan-d9 REF: TM-T13282CAS: 1089736-73-1 | 98% | A consultar | Ter 03 Dez 24 | |
Valsartan-d9 (Major) REF: TR-V095753CAS: 1089736-73-1 | - - - | 348,00 €~2.391,00 € | Ter 10 Dez 24 | |
Valsartan-d9 (Major) REF: 3D-PTB73673CAS: 1089736-73-1 | Min. 95% | A consultar | Seg 13 Jan 25 |
rac-Valsartan-d9
Ref: 4Z-V-022
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Valsartan-d9
Ref: 4Z-V-0248
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Valsartan-d9
Ref: TM-T13282
1mg | 295,00 € | ||
5mg | 707,00 € |
Valsartan-d9 (Major)
Produto ControladoRef: TR-V095753
1mg | 348,00 € | ||
10mg | 2.391,00 € |
Valsartan-d9 (Major)
Ref: 3D-PTB73673
1mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |